News

Neurosoft Bioelectronics Receives Nearly $3 Million in Funding

Neurosoft Bioelectronics was awarded nearly $3 million, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 through the European Research Council Proof-of-Concept Grant. Additionally, the firm secured a $100,000 convertible note from the Fongit Innovation Fund. Proceeds will fund clinical study and regulatory approval for epilepsy and advance development for tinnitus application.

Neurosoft Bioelectronics adds experts in Neuromodulation & Tinnitus to its Advisory Board

Geneva, Switzerland, 9 December 2021 – Neurosoft Bioelectronics SA, a startup developing the first fully-implantable Brain-Computer Interface(BCI)to treat severe tinnitus, announced two new members to its Advisory Board. Prof. Dirk de Ridder and Dr. Christian Hauptmann, two experts in neuromodulation and tinnitus, join the advisory board to shape and guide the technical and clinical development of a fully-implantable BCI to treat severe tinnitus through cortical neuromodulation.

Welcome to Olivia Molloy – our new Process Engineer

Olivia has a BSc in Microbiology and Biochemistry from the National University of Ireland, Galway (NUIG). Over the past 6 years, she has gained significant experience in the Medical Device Industry, primarily in the R&D and manufacturing sector of leading MedTech companies such as Medtronic, Boston Scientific, and Baylis. Welcome to the team, Olivia!

Neurosoft Bioelectronics selected for the Medlim Fast Track Acceleration Program

We are very pleased to announce that Neurosoft Bioelectronics has been selected to participate in the Medlim Fast Track Acceleration Program. This year the program has selected 9 promising startups developing breakthrough technology in the Cardiovascular, Diabetes, Neurological & Orthopedic fields. Each startup will receive support in bringing their medical devices to the market through workshops, interaction with experts, coaching sessions and a final pitch event with investors.

Welcome to Chloé Fattebert – our new Quality Assurance Manager

Chloé holds a BSc in Microengineering from the HES-SO, and has gained significant experience over the past 8 years working in the Medical Device Industry. As a QA/RA consultant, she specialized in audits, regulatory strategy, manufacturing processes, product quality management, and QMS implementation for novel medical devices, including active implantables. She later worked as QA/RA Director in the endodontic field, leading the team in charge of MDR transition, quality & regulatory strategy, product portfolio optimization, device worldwide registration, and Technical Documentation. Welcome to the team, Chloé!